Alopecia Areata: all 469 studies

Page 2 of 5. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.

• Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia AreataTerminatedNCT05278858Phase 4Results posted
• European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia AreataCompletedNCT05041803Phase 3Results posted
• Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).CompletedNCT04898166Results posted
• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)CompletedNCT04797650Phase 3Results posted
• A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia AreataCompletedNCT04784533Phase 2Results posted
• Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia AreataCompletedNCT04556734Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)CompletedNCT04518995Phase 3Results posted
• PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATATerminatedNCT04517864Phase 2Results posted
• Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing AlopeciaCompletedNCT04409041Phase 2Results posted
• Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needlingCompletedNCT04342091Not applicableResults posted
• Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needlingCompletedNCT04341363Not applicableResults posted
• Tofacitinib for Immune Skin Conditions in Down SyndromeCompletedNCT04246372Phase 2Results posted
• Modulated Light Therapy in Participants With Pattern Hair LossCompletedNCT04019795Not applicableResults posted
• Long-Term PF-06651600 for the Treatment of Alopecia AreataCompletedNCT04006457Phase 3Results posted
• Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia AreataCompletedNCT03941548Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia AreataCompletedNCT03899259Phase 3Results posted
• Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia AreataCompletedNCT03811912Phase 2Results posted
• Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia AreataCompletedNCT03800979Phase 4Results posted
• ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)TerminatedNCT03759340Phase 2Results posted
• Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%CompletedNCT03753113Phase 3Results posted
• PF-06651600 for the Treatment of Alopecia AreataCompletedNCT03732807Phase 2/3Results posted
• The Effect of Platelet Rich Plasma on Non-scarring AlopeciaCompletedNCT03689452Not applicableResults posted
• DPCP for the Treatment of Alopecia AreataTerminatedNCT03651752Phase 3Results posted
• Pain Outcomes Following Intralesional Corticosteroid InjectionsCompletedNCT03630198Phase 4Results posted
• ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia TotalisCompletedNCT03594227Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia AreataCompletedNCT03570749Phase 2/3Results posted
• Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia AreataCompletedNCT03551821Phase 2Results posted
• Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)CompletedNCT03521687Phase 4Results posted
• A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical SolutionCompletedNCT03495817Phase 2Results posted
• Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in WomenCompletedNCT03488108Phase 1/2Results posted
• Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)CompletedNCT03359356Phase 2Results posted
• A Study of ATI-50002 Topical Solution for the Treatment of Alopecia AreataTerminatedNCT03354637Phase 2Results posted
• Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)CompletedNCT03315689Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia AreataCompletedNCT03137381Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic AlopeciaCompletedNCT03004469Phase 3Results posted
• Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia AreataCompletedNCT02974868Phase 2Results posted
• Topical Tofacitinib for the Treatment of Alopecia Areata and Its VariantsCompletedNCT02812342Phase 2Results posted
• A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in MalesCompletedNCT02781311Phase 2Results posted
• Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia AreataCompletedNCT02684123Not applicableResults posted
• A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia AreataCompletedNCT02684097Phase 2Results posted
• Adipose-derived SVF for Treatment of AlopeciaCompletedNCT02626780Not applicableResults posted
• A Study of Secukinumab for the Treatment of Alopecia AreataTerminatedNCT02599129Phase 2Results posted
• LEO 124249 Ointment in the Treatment of Alopecia AreataCompletedNCT02561585Phase 2Results posted
• A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)TerminatedNCT02553330Phase 2Results posted
• STYLE -- A Trial of Cell Enriched Adipose For Androgenetic AlopeciaCompletedNCT02503852Not applicableResults posted
• Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic AlopeciaCompletedNCT02460497Not applicableResults posted
• Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic AlopeciaCompletedNCT02460289Not applicableResults posted
• Tofacitinib for the Treatment of Alopecia Areata and Its VariantsCompletedNCT02312882Not applicableResults posted
• Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And UniversalisCompletedNCT02299297Phase 2Results posted
• Tofacitnib for the Treatment of Alopecia Areata and VariantsCompletedNCT02197455Phase 2Results posted
• Topical Bimatoprost Effect on Androgen Dependent Hair FolliclesCompletedNCT02170662Phase 2Results posted
• An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia AreataCompletedNCT02018042Phase 2Results posted
• Sexual Function in Men Receiving Dutasteride for Androgenetic AlopeciaCompletedNCT02014584Phase 3Results posted
• Scalp Cooling to Prevent Chemo-induced Hair LossStatus unknownNCT01986140Not applicableResults posted
• A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser TherapyCompletedNCT01967277Not applicableResults posted
• Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia AreataCompletedNCT01950780Phase 2Results posted
• A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)CompletedNCT01904721Phase 2Results posted
• Intralesional Steroids in the Treatment of Alopecia AreataTerminatedNCT01898806Phase 4Results posted
• A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic AlopeciaCompletedNCT01831791Phase 3Results posted
• Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia AreataCompletedNCT01797432Phase 2Results posted
• Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and FemalesCompletedNCT01701271Not applicableResults posted
• Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic AlopeciaCompletedNCT01325337Phase 2Results posted
• Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human ScalpTerminatedNCT01292746Not applicableResults posted
• Dutasteride Versus Placebo and Finasteride in Men With Androgenetic AlopeciaCompletedNCT01231607Phase 3Results posted
• Clinical Trial in Females for Female Pattern Hair LossCompletedNCT01226459Phase 3Results posted
• Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With AlopeciaCompletedNCT01189279Phase 1Results posted
• Clinical Trial in Females With Female Pattern Hair LossCompletedNCT01145625Phase 3Results posted
• Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in ChildrenCompletedNCT01023841Phase 4Results posted
• Treatment of Androgenetic Alopecia in Females, 12 BeamCompletedNCT01016964Not applicableResults posted
• Treatment of Androgenetic Alopecia in Females, 9 BeamCompletedNCT00981461Not applicableResults posted
• Treatment of Androgenetic Alopecia in MalesCompletedNCT00947505Not applicableResults posted
• Treatment of Androgenic Alopecia in MalesCompletedNCT00947219Not applicableResults posted
• Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia AreataCompletedNCT00484679Phase 2Results posted
• A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic AlopeciaCompletedNCT00441116Phase 3Results posted
• Alefacept in Patients With Severe Scalp Alopecia AreataCompletedNCT00167102Not applicableResults posted
• Real-World Effectiveness of Ritlecitinib in Alopecia Areata Patients in the US: A Retrospective Analysis Using EHR and Claims DataActive, not recruitingNCT07821216
• Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia AreataCompletedNCT07757867Not applicable
• Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.CompletedNCT07645430Not applicable
• Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia AreataCompletedNCT07455708
• Association of TLR7 Gene rs3853839 Polymorphism With Disease Severity in Alopecia Areata: A Case-Control StudyCompletedNCT07454876
• Comparison of Microneedling Along With Topical Vitamin D3 Versus Microneedling in Alopecia AreataActive, not recruitingNCT07243977Not applicable
• Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USCompletedNCT07226531
• A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world SettingsCompletedNCT07200128
• Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia AreataCompletedNCT07174011Phase 4
• Rhofanib® (Tofacitinib) Safety and Effectiveness EvaluationCompletedNCT07101471
• The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.CompletedNCT07046039
• A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia AreataActive, not recruitingNCT07029711Phase 3
• Intralesional Cyclosporine for Alopecia AreataActive, not recruitingNCT07029204Early Phase 1
• A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia AreataActive, not recruitingNCT07023302Phase 3
• A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.Active, not recruitingNCT07011485Phase 2
• Evaluation of the Niostem Headset for Hair Growth and Hair QualityCompletedNCT06994819Not applicable
• Exosome Treatment and Hair GrowthCompletedNCT06930326Not applicable
• A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.Active, not recruitingNCT06920758Not applicable
• Clinical Evaluation of Localized Scalp Thread Embedding for Male Androgenetic AlopeciaCompletedNCT06879119Not applicable
• Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic AlopeciaTerminatedNCT06854432Not applicable
• Psychosocial Stress on QOL in Saudi Arabian Patients With Alopecia AreataCompletedNCT06802705
• A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)Active, not recruitingNCT06799520Phase 1
• To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia AreataCompletedNCT06786689Phase 2
• Umbilical Cord-derived Mesenchymal Stem Cell Exosomes on Hair Growth in Patients With Androgenetic AlopeciaActive, not recruitingNCT06697080Not applicable
• To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult MalesCompletedNCT06692465Phase 2

← Alopecia Areata overview